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Expression of human Cfdp1 gene in 
Drosophila reveals new insights into 
the function of the evolutionarily 
conserved BCNT protein family
Giovanni Messina1, Maria Teresa Atterrato1, Laura Fanti1, Ennio Giordano2 & Patrizio Dimitri1
The Bucentaur (BCNT) protein family is widely distributed in eukaryotes and is characterized by a highly 
conserved C-terminal domain. This family was identified two decades ago in ruminants, but its role(s) 
remained largely unknown. Investigating cellular functions and mechanism of action of BCNT proteins 
is challenging, because they have been implicated in human craniofacial development. Recently, 
we found that YETI, the D. melanogaster BCNT, is a chromatin factor that participates to H2A.V 
deposition. Here we report the effects of in vivo expression of CFDP1, the human BCNT protein, in 
Drosophila melanogaster. We show that CFDP1, similarly to YETI, binds to chromatin and its expression 
results in a wide range of abnormalities highly reminiscent of those observed in Yeti null mutants. 
This indicates that CFDP1 expressed in flies behaves in a dominant negative fashion disrupting the 
YETI function. Moreover, GST pull-down provides evidence indicating that 1) both YETI and CFDP1 
undergo homodimerization and 2) YETI and CFDP1 physically interact each other by forming inactive 
heterodimers that would trigger the observed dominant-negative effect. Overall, our findings highlight 
unanticipated evidences suggesting that homodimerization mediated by the BCNT domain is integral 
to the chromatin functions of BCNT proteins.
The human craniofacial development protein 1 (CFDP1) is a 299 amino acid long polypeptide which belongs to 
the evolutionarily conserved family of Bucentaur (BCNT) proteins (Fig. 1) characterized by a highly conserved 
C- terminal BCNT domain1,2. Despite its widespread distribution in animals and plants, the function(s) and 
mechanism(s) of action of BCNT proteins need to be clarified.
Defects of craniofacial development represent the main cause of infant mortality and disability in humans, but 
the genetic causes and underlying developmental etiology remain largely unknown. Several lines of evidence are 
suggestive for an involvement of Cfdp1 gene orthologs in craniofacial development of vertebrates. First, human 
Cfdp1 gene maps to chromosome 16 in 16q22.2-q22.3, in proximity to several loci associated with inherited 
craniofacial disease genes3. Second, human Cfdp1 was shown to be a target of the TFII-I transcription factors, 
which are in turn encoded by genes suggested to be primary candidate genes responsible for craniofacial abnor-
malities and other defects associated with the Williams-Beuren disease4. Third, mouse Cfdp1, also called CP27, 
is up-regulated during experimentally induced osteodifferentiation in mouse and is therefore proposed to be 
required for bone differentiation5. Fourth, cleft palate induced in mouse by persistent expression of PAX 3 gene in 
neural crest correlated with Cfdp1 down-regulation6. Finally, in zebrafish, the CFDP1 protein, also called RLTPR, 
is expressed in the branchial arches7 which lead to the craniofacial structures.
Recent findings on the Drosophila YETI protein indeed provided the first experimental evidence showing 
that members of the BCNT family can be essential for proper development and individual viability8. Moreover, 
functional studies suggest that in different organisms the BCNT proteins play a conserved role in chromatin reg-
ulation. In particular, yeast SWC5, D. melanogaster YETI and human CFDP1 belong to related ATP-dependent 
chromatin remodeling complexes of INO-80 family that share evolutionary conserved subunits and catalyze the 
exchange of histone variant H2A.V with the canonical H2A8–10.
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Experimental evidence accumulated in the last decade showed that mutations in genes encoding proteins 
governing chromatin architecture and function can affect dramatically cell differentiation and cause complex 
human developmental disorders11–14. It is then clear that, the characterization of chromatin factors controlling 
cell differentiation represents a foothold for the comprehension of mechanisms underlying the onset of human 
developmental diseases.
Here, using a multidisciplinary experimental approach, we studied the effects of human Cfdp1 transgene 
expression in Drosophila melanogaster. We found that when expressed in wild-type flies, CFDP1 protein binds to 
Figure 1. The BCNT protein family. (A) Blast alignments of BCNT protein sequences from Saccharomyces 
cerevisiae, Danio rerio (zebrafish), Drosophila melanogaster, Mus musculus and Homo sapiens. (B) The closest 
match between human CFDP1 and Drosophila YETI (50% identity) is found in the last 82 amino acids of the 
C-terminus and is called BCNT-domain.
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chromatin and behaves as a dominant-negative leading to diverse phenotypic defects similar to those produced 
by the lack of endogenous YETI8. In addition, using GST-pull down assays, we found that both YETI and CFDP1 
undergo self-interactions and can physically interact each other. These results strongly suggest that both proteins 
are able to form homodimers in vivo and that, when simultaneously expressed in the same cells, can undergo 
heterodimerization which in turn would trigger the dominant negative effect observed in flies.
Overall, these findings are relevant in that they shed new light into unanticipated mechanistic clues of BCNT 
proteins and have impact on both basic and applied biomedical research.
Results
Ectopic expression of human Cfdp1 transgene in D. melanogaster results in lethality and 
developmental defects. In order to investigate the effect of Cfdp1 gene expression in flies, we constructed 
D. melanogaster transgenic lines carrying the Cfdp1 human c-DNA under control of UAS regulatory sequences 
(see Material and Methods). Overexpression of the CFDP1 protein in D. melanogaster was performed by crossing 
two transgenic UAS-Cfdp1 lines (15 and 16) to lines carrying ubiquitously active or tissue-specific GAL4 driv-
ers. Western blotting analysis using a monoclonal antibody directed against CFDP1 was performed on protein 
extracts from human HeLa cells and from w, elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ larvae carrying the UAS-Cfdp1 
transgene under control of the elev-GAL4 driver (Fig. 2; see Material and Methods for description of genetic 
crosses).
In HeLa cells, the anti-CFDP1 detected two sharp bands of about 50 kDa and 35 kDa (Fig. 2A), a result that 
is in accord with the existence of two isoforms of the protein produced by alternative splicing1. However, both 
bands have an apparently molecular weight higher than expected; in particular CFDP1 is 299 amino acids long 
and has a calculated molecular weight of 33.6 kDa. Such unusual mobility on SDS/PAGE was found to be due to 
an acidic stretch located at the N-terminal region of the protein15. In protein extracts from w, elav-GAL4[w+]/w; 
UAS-Cfdp1[w+]/+ female larvae, as espected the anti-CFDP1 recognizes only the band of about 50 kDa (Fig. 2A), 
produced by UAS-Cfdp1 transgene expression; no staining is seen in w/Y; UAS-Cfdp1[w+]/+ control male larvae 
lacking the elav-GAL4 driver (not shown).
Expression of UAS-Cfdp1 transgenes in wild-type flies results in lethality and phenotypic abnormalities, 
depending on the driver used (Fig. 2B–D). With GMR-GAL4, an eye specific driver, ommatidia differentiation is 
affected (Fig. 2B), while with Ms1096-GAL4 driver which is expressed throughout the wing pouch, a vestigial-like 
wing phenotype is produced (Fig. 2C). Expression of UAS-Cfdp1 transgene driven by tub-GAL4 or elav-GAL4 
induce strong lethality that mainly occurs at second/third instar larvae or pupal stages. The tub-GAL4 driver is 
ubiquitously active, while elav-GAL4, was found to be expressed throughout the larval central nervous system 
and in peripheral sensory neurons as well as at all NMJs16. In addition, elav-GAL4 driven expression of UAS trans-
genes was also detected in larval salivary gland cells8,17. Notably, w, elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ female 
larvae exhibited severely reduced brains and imaginal discs, with sporadic melanotic masses in their hemocoel 
(Fig. 2D) and are characterized by prolonged larval development. In addition, most of the pupae metamor-
phose and die at the adult pharate stage. Notably, about 10% of pharate adults show the failure of head eversion 
(Fig. 2D); only few escapers (about 1%) were found. Similar head eversion defects can results from abnormalities 
of muscular functions following how-GAL4 driven expression in mesoderm and larval muscles of a transgene 
encoding a truncated form of Gemini3 motor protein18. We tested UAS-Cfdp1 expression driven by how-GAL4 
and found strong pupal lethality and head eversion defects (not shown). It is then possible that CFDP1 expression 
driven by elav-GAL4 in nervous system also affect muscular functions which result in failure of head eversion.
Finally, we tested the ability of UAS-Cfdp1 to rescue or mitigate the lethal phenotype of Yeti mutants by genetic 
crosses. Overexpression of UAS-Cfdp1 transgene was induced by the tub-GAL4 driver in w, UAS-Cfdp1[w+]/Y; 
LP1/LP1; tub-GAL4[w+]/+ individuals that are homozygous for LP1, a loss-of-function allele of the Yeti gene8. The 
results showed that expression of UAS-Cfdp1 fails to rescue the lethality due to the lack of YETI protein.
CFDP1 binding to polytene chromosomes results in altered chromatin organization. In a pre-
vious study, we demonstrated that higher order chromosome organization and deposition of both H2A.V and 
H2A are severely impaired in Yeti null mutants8. We then examined salivary gland polytene chromosome mor-
phology and chromosomal levels of both H2A.V and H2A in w, elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ larvae and 
in UAS-Cfdp1[w+]/UAS-Cfdp1[w+] control larvae lacking the elav-GAL4 driver. We found that about 66% of sali-
vary gland cells show highly disorganized polytene chromosome organization compared to those of the control 
strain (Fig. 3A). In addition, the results of immunostaining experiments clearly show strong decrease in H2A.V 
and H2A protein levels on polytene chromosomes of w, elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ female larvae, com-
pared to the controls (Fig. 3B–E and Supplementary Fig. 1). Western blotting assays of whole protein extracts 
from larval salivary gland and brains also depicted a reduced overall amount of H2A.V and H2A proteins in 
elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ (Fig. 4A,B).
It is possible that strong decrease in H2A.V and H2A protein levels and impairment of chromosome organiza-
tion are aberrant consequences due to the binding of the CFDP1 protein to chromatin in Drosophila cells. To test 
this hypothesis and to get further insight into the function of CFDP1, salivary gland polytene chromosomes of 
w, elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ female larvae were immunostained with anti-CFDP1 antibody. As 
shown in Fig. 3F, this antibody produces strong staining of polytene chromosomes with some appearance of 
banding, while no staining was observed on polytene chromosomes of either w/Y; UAS-Cfdp1[w+]/+ male or 
UAS-Cfdp1[w+]/UAS-Cfdp1[w+] female larvae lacking the elav-GAL4 driver (not shown).
Together, these data indicate that CFDP1 binding to chromatin, results in depletion of both H2A and H2A.V, 
which in turn may produce a cascade effect disrupting chromatin/chromosome organization.
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Simultaneous expression of UAS-Cfdp1 and UAS-Yeti-GFP transgenes in D. melanogaster. 
Overall, the phenotypes of lethality, prolonged larval development, reduced brain and imaginal disc size and 
highly disorganized polytene chromosomes organization, together with decreased levels of H2A.V and H2A 
found in w, elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ larvae are highly reminiscent of the aberrant effects found in Yeti 
null mutants8. It is then conceivable that expression of the CFDP1 protein in flies induces a dominant-negative 
effect possibly disrupting the function of endogenous YETI, as reported for other human genes expressed in 
Drosophila19.
We demonstrated previously that YETI-GFP fusion protein binds to polytene chromosomes where it is 
recruited at DAPI-positive bands8. Here, we took advantage of YETI-GFP expression, to test whether the defects 
due to activation of UAS-Cfdp1 could be due to depletion of endogenous YETI from chromatin. We performed 
sequential immunostaining of polytene chromosomes of larvae expressing UAS-Cfdp1 and UAS-Yeti-GFP 
Figure 2. Expression of UAS-Cfdp1 transgene activated by different GAL-4 drivers. (A) Western blotting 
with anti-CFDP1 antibody of protein estracts from HeLa cells (lane 1) and from salivary glands and brains of 
elav-GAL4; UAS-CFDP1 larvae (lane 2). Two bands of about 50 kDa and 35 kDa were detected by the anti-CFDP1 
in Hela cells, while a single 50 kDa band was found in in elav-GAL4; UAS-Cfdp1 larvae. (B) Overexpression of 
UAS-Cfdp1 induced by GMR-GAL4; compared to the wild-type eye (left panel), the glazed-like phenotype consist 
in lack of ommatidia differentiation (left panel); the phenotype shows a 100% penetrance. (C) Overexpression 
of UAS-Cfdp1 induced by the MS1096-GAL4 driver causes strong reduction of wings portions. The phenotype 
shows a 100% penetrance. (D) Normal sized brain and imaginal discs of larvae carrying the UAS-Cfdp1 trangene 
that is not activated (left panel, upper part); severely reduced brain and imaginal discs of larvae expressing 
UAS-Cfdp1 (left panel, lower part); 60/266 (22%) dying larvae also develop sporadic melanotic masses in their 
hemocoel (middle panel), while 15/140 (10%) pharate adults show the failure of head eversion (right panel). 
Among 140 pupae only two vital adults (about 1%) were found. No effects were seen in the GAL4 driver control 
flies lacking UAS-Cfdp1 transgene.
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transgenes, to visualize simultaneously both CFDP1 and YETI-GFP. The results of this experiment show that 
YETI-GFP and CFDP1 proteins mainly colocalize on the same polytene chromosomes, with CFDP1 showing 
a slightly broader distribution (Fig. 5A,B). Most importantly, looking at polytene chromosome banding pattern 
of YETI-GFP in genetic background expressing YETI-GFP alone8 or both YETI-GFP and CFDP1 (Fig. 5A,B), it 
appears that the distribution of the fusion protein is unaffected, at least at cytological level.
Together, these results show that CFDP1 and YETI-GFP share a similar pattern of recruitment on polyt-
ene chromosomes and indicate that both lethality and aberrant phenotypes induced by CFDP1 expression in 
D. melanogaster are unlikely to be due to significant depletion of endogenous YETI protein from chromosomes.
GST pull-down experiments. On the light of the above results, it is possible that aberrant effects produced 
by UAS-Cfdp1 expression in flies may be due to the in vivo formation of YETI-CFDP1 inactive heterodimers. If 
this was true, we also expect that both proteins should be able to undergo physiologically self-dimerization.
To test these hypotheses, we performed GST pull-down experiments. Whole lysates from larvae express-
ing 3xFLAG::YETI protein under control of elav-GAL4 driver, were incubated with GST alone, GST::YETI or 
GST::CFDP1 fusion proteins and analyzed by Western blot using anti-Flag antibody. As shown in Fig. 6A, both 
YETI and CFDP1 fusion protein, but not GST alone, specifically pulled down 3xFLAG::YETI. The interaction 
between CFDP1 and YETI was confirmed using GST::YETI to pull down CFDP1 protein from extracts of larvae 
expressing the UAS-Cfdp1 transgene under control of elav-GAL4 driver. As expected, the interaction of CFDP1 
protein is apparent with GST::YETI, but not with GST alone (Fig. 6B).
Moreover, to test whether CFDP1 is able to undergo self-dimerization, we also performed GST pull-down 
assay with GST::CFDP1 using a lysate from HeLa cells transfected with pcDNA3.1/nV5-DEST::CFDP1. As 
shown in Fig. 6C, V5::CFDP1 fusion protein is detectable using anti-V5 antibody in samples pulled down by 
GST::CFDP1, but not by GST alone. Taken together, these findings indicate that both YETI and CFDP1 are 
Figure 3. Chromatin defects in elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ larvae. (A) Comparison between 
polytene chromosomes of wild-type Oregon-R (left panel) and w, elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ (right 
panel) larvae stained with DAPI. Chromosome structure is highly disorganised in larvae expressing UAS-Cfdp1. 
Chromosome morphology was strongly affect in 231/350 (66%) figures scored were scored from three different 
replicates of the same cross. (B) Polytene chromosomes of UAS-Cfdp1[w+]/UAS-Cfdp1[w+] larvae which do not 
express CFDP1 protein stained with DAPI (left panels); multiple H2A.V signals are present (right panel);  
(C) Polytene chromosomes of w, elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ larvae (left panel); H2A.V protein levels 
are decreased (right panel); (D) Polytene chromosomes of UAS-Cfdp1[w+]/UAS-Cfdp1[w+] larvae stained with 
DAPI (left panels); multiple H2A signals are present (right panel); (E) Polytene chromosomes of w, elav-
GAL4[w+]/w; UAS-Cfdp1[w+]/+ larvae (left panel); H2A protein levels are decreased (right panel); (F) Polytene 
chromosomes of w, elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ larvae stained with DAPI (left panel); strong staining 
with anti-CFDP1 antibody (right panel); in this case chromosome morphology is not dramatically affected.
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able to undergo self-dimerization and that, when expressed simultaneously in the same cells, can form inactive 
YETI-CFDP1 heterodimers that bind chromatin.
Moreover, to map the portion of the YETI protein implicated in self-interactions, we tested the N-terminal 
or C-terminal portion of YETI in GST assays. Whole lysates from larvae expressing both 3xFLAG::YETI-N-ter 
and 3xFLAG::YETI-C-ter fusion proteins8, under control of elav-GAL4 driver were incubated with GST alone 
or with GST::YETI fusion protein and analyzed by Western blot using anti-Flag antibody. As shown in Fig. 6D, 
GST::YETI specifically pull-down 3xFLAG::YETI-C-ter that corresponds to the highly conserved C-terminal 
BCNT domain8. This result provides evidence for a role of YETI BCNT domain in mediating homodimerization.
Discussion
To investigate the function and mechanism of action of CFDP1 protein, we have studied the in vivo effects of its 
expression in D. melanogaster. We found that when overexpressed in wild-type flies, CFDP1 binds to chromatin 
and causes the following defects: disruption of polytene chromosome organization, decreased levels of H2A.V 
and H2A, reduction of brains and imaginal discs size, occurrence of melanotic masses, prolonged larval devel-
opment and lethality (Figs 2–4 and Supplementary Fig. 1). It is worth noting that all these aberrant phenotypes, 
rather than being the result of a generalized disruption of development, have been observed in Yeti null mutants8. 
Then, it appears that the expression of CFDP1 in D. melanogaster is likely to disrupt the normal function of YETI 
and results in a dominant-negative effect.
What the molecular nature of such dominant negative effect may be? Three hypotheses can be considered. 
First, the aberrant phenotypes produced by CFDP1 expression may be explained in terms of competition between 
CFDP1 and YETI proteins for binding to chromatin targets, which may result in a significant depletion of YETI 
from chromatin. Second, YETI-CFDP1 heterodimers can efficiently be formed in vivo, but they are unable to 
bind chromatin, thus resulting in a depletion of YETI from chromatin. However, the observation that polytene 
chromosome distribution and levels of YETI-GFP are not significantly affected, at least at a cytological level, 
when simultaneously expressed together with CFDP1 (Fig. 5A,B), strongly argues against these two hypotheses. 
Third, the dominant negative effect may be due to in vivo formation of YETI-CFDP1 heterodimers still capable 
Figure 4. Decrease of total amount of H2A.V and H2A from protein extracts. Western blot showing the 
overall amount of H2A.V (A) and H2A (B) in elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ larvae expressing CFDP1 
protein (activated) and in UAS-Cfdp1[w+]/UAS-Cfdp1[w+] control larvae which do not express CFDP1 (non 
activated). 50% and 25% dilutions of protein extracts were also loaded. The α -tubulin is used as loading control. 
A significant decrease in the total amount of both H2A.V and H2A is evident in activated larvae compared to 
non activated controls.
www.nature.com/scientificreports/
7Scientific RepoRts | 6:25511 | DOI: 10.1038/srep25511
of binding to chromatin, but unable to establish further interactions with specific partners of YETI. It has indeed 
been reported that the expression of human genes in D. melanogaster is responsible for dominant negative effects, 
through titration of endogenous proteins by the human counterpart to form inactive heterodimers16.
The latter hypothesis gained experimental support by the results of our cytological and biochemical experi-
ments. First, simultaneous immunolocalization of CFDP1 and YETI-GFP on polytene chromosome showed that 
these proteins mainly colocalizes at multiple chromosomal sites (Fig. 5). Second, GST pull-down assays provide 
evidence for physical interaction between CFDP1 and YETI (Fig. 6A,B).
Together, these findings converge in indicating that the dominant negative effect produced by CFDP1 expres-
sion is most likely due to the binding of YETI-CFDP1 heterodimers to chromatin. This would result in overall 
depletion of functional YETI protein and disruption of H2A/H2A.V exchange, similarly to what we found in Yeti 
null genetic background8. A consequent breakdown of chromatin organization would then occur, thus altering 
global gene expression and leading to phenotypic abnormalities similar to those produced by the lack of YETI 
protein8.
Moreover, GST pull-down assays indicated that both YETI and CFDP1 can undergo self-interactions 
(Fig. 6A,C), Notably, in the case of YETI, the C-terminal BCNT domain may be implicated in mediating 
self-interaction (Fig. 6D).
Although, we cannot completely rule out the possibility that a fraction of CFDP1 homodimers can form in 
D. melanogaster cells and bind separately to chromatin, it is unlikely that this would explain the occurrence of the 
observed dominant negative effect.
The human CFDP1 and Drosophila YETI proteins share a similar function in chromatin remodeling1,2. 
However, we found that the expression of UAS-Yeti rescues the lethality of Yeti null mutants, while that of 
UAS-Cfdp1 does not8. How to explain this result? It is important to point out that at the amino acid level the 
highest identity between the two proteins (about 50%) is found in the evolutionarily conserved BCNT domain1,2 
(Fig. 1B), that is likely to play a functional role. Our data indeed suggest that dimerization is a conserved func-
tional trait of BCNT domain. On the light of these results, the inability of human CFDP1 to rescue the lack of 
YETI in D. melanogaster can be interpreted as due to a lower conservation between the two proteins found in the 
remaining portion of their amino acid sequence (Fig. 1A,B).
Several chromatin proteins are known to undergo homodimerization in vivo through coiled coil interac-
tions20–26. Interestingly, the secondary structure analysis of both CFDP1 and YETI predicts coiled-coil α -helix 
stretches located at their C-terminal portion corresponding to the BCNT domain (Supplementary Fig. 2).
Figure 5. CFDP1 colocalizes with and YETI-GFP on polytene chromosome of w, elav-GAL4[w+]/w; UAS-
Yeti GFP [w+]/UAS-Cfdp1[w+] larvae. Polytene chromosomes from w, elav-GAL4[w+]/w; Yeti-GFP[w+]/UAS-
Cfdp1[w+] female larval progeny were stained with DAPI (blue) and immunostained with both anti-GFP (green) 
and anti-CFDP1 (red) antibodies. (A,B) YETI-GFP is recruited at DAPI-positive bands; the same patter has 
been observed when YETI-GFP is expressed in absence of CFDP18; YETI-GFP and CFDP1 proteins mainly 
colocalize, with CFDP1 showing a slightly broader distribution. (B) A detail of 3R chromosome clearly showing 
the recruitment of YETI-GFP at DAPI-positive bands. Polytene chromosome bands 93A, 94, 96A, 98B and 
99EF are shown as landmarks.
www.nature.com/scientificreports/
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These findings, together with the results of our previous study showing that the BCNT domain of YETI is 
required for binding to polytene chromosomes8, suggest that homodimerization is also necessary to promote the 
chromatin binding ability of YETI and more in general of BCNT proteins. A scheme summarizing our model of 
homodimer and heterodimer formation is shown in Fig. 7.
In conclusion, by combining genetics, cytological and biochemical approaches, we shed new light on the 
mechanism of action of YETI and CFDP1 proteins. In particular, we provide the first experimental evidence 
suggesting that BCNT proteins can undergo in vivo homodimerization mediated by the evolutionarily conserved 
BCNT domain. These results are also relevant to biomedical research, since mutations of Cfdp1 gene has been 
implicated in the onset of craniofacial anomalies that represent one of the main cause of infant mortality and 
disability in humans.
Methods
Drosophila strains and genetic crosses. Fly cultures and crosses were carried out at 25 °C in stand-
ard cornmeal yeast medium. The GAL4-driver lines used in this work were obtained from the Bloomington 
Drosophila Stock Center. Overexpression the human CFDP1 protein in D. melanogaster was induced in the 
offspring of crosses between transgenic w/w; UAS-Cfdp1[w+]/UAS-Cfdp1[w+] homozygous females and males of 
different GAL4 drivers. For example, to induce CFDP1 expression in salivary glands cells, w/w; UAS-Cfdp1[w+]/
UAS-Cfdp1[w+] homozygous females were crossed to w, elav-GAL4[w+]/Y; + /+ males to obtain w, elav-
GAL4[w+]/w; UAS-Cfdp1[w+]/+ larval female progeny. Among the male offspring of these crosses, the control is 
represented by w/Y; UAS-Cfdp1[w+]/+ males lacking the elav-GAL4 driver. Overexpression of CFDP1 was induced 
Figure 6. GST-pull down assayes. (A) GST-pull down experiments were performed with the indicated GST, 
GST::YETI and GST::CFDP1 fusion proteins, which were incubated with whole Drosophila larvae lysates 
expressing FLAG::YETI. (B) GST-pull-down assay with GST, GST::YETI, and whole larvae extracts expressing 
CFDP1 protein. (C) GST pull-down assay with GST (control) and GST::CFDP1 (Pull-down) of mammalian 
HeLa cells extracts expressing V5::CFDP1. (D) GST-pull-down assay with GST, GST::YETI, and whole 
larvae extracts expressing 3xFLAG::YETI-N-ter or 3xFLAG::YETI-C-ter proteins. GST::YETI pulled down 
3xFLAG::YETI-C-ter, but not 3xFLAG::YETI-N-ter. Bound proteins were analyzed by SDS–PAGE, followed 
by western blotting with antibodies against the FLAG-tag (A,D), CFDP1 (B) and V5-Tag (C). Total protein 
extracts were used as control (input). Two GST-pull down replicates were performed.
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in both wild-type and Yeti mutant backgrounds. Simultaneous expression of YETI-GFP and CFDP1 proteins was 
obtained by crossing w, elav-GAL4[w+]/w, elav-GAL4[w+]/UAS-Yeti-GFP/Yeti-GFP females to w/Y; UAS-Cfdp1[w+]/
UAS-Cfdp1[w+] males. The full-length YETI amino acid sequence is 241 amino acids in lenght; 3XFLAG::YETI-
Nter corrisponds to residues 1–166, while 3xFLAG::YETI-C-ter corresponds to 145–241. The BCNT domain 
corresponds to to residues 159–238. A detailed description of these lines can be found in ref. 8.
Generation of UAS-Cfdp1 transgenic lines. D. melanogaster carrying the UAS-Cfdp1 transgene were 
generated as follows: The full ORF of Cfdp1 gene was introduced downstream of the UAS regulatory sequences of 
the pUAST transformation vector. The pUAST-Cfdp1 construct was injected in D. melanogaster pre-blastoderm 
embryos of genotype w1118 and transgenic flies were selected using the white+ phenotypic marker. We isolated 
and balanced three lines called, 3, 15 and 16. Line 3 was mapped to the X chromosome, while line 15 and 16 were 
mapped to chromosomes 2 and 3, respectively.
Cytology and immunostaining. Immunolocalization experiments to Drosophila polytene chromosomes 
were according to Deuring et al. 25. Anti-GFP rabbit polyclonal antibodies was used at 1:100 dilution, while 
anti-CFDP1 mouse monocolonal antibodies (Abnova, H00010428-M4, clone 5B7) at 1:50. Anti-H2A.V or 
Figure 7. Model for homodimerization of YETI and CFDP1 and heterodimer formation. (A,B) Self-
association of YETI and CFDP1 to form functional dimers in Drosophila and human cells, respectively.  
(C) Formation of YETI-CFDP1 inactive heterodimers capable of binding to chromatin, but unable to establish 
further interactions with specific partners of YETI. Dark-blue dashed lines indicate the interactions between 
C-terminal BCNT domains.
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anti-H2A (Millipore) antibodies were used at 1:100 dilution. After three washes in PBS, they were incubated 
with secondary antibodies Alexa Fluor 555 goat anti-rabbit IgG (1:300) for 1 h at room temperature and DAPI 
were used to DNA staining. Polytene chromosome preparations were analyzed by using a computer-controlled 
Nikon Eclipse 50i epifluorescence microscope equipped with a CCD camera. Measurements of polytene chro-
mosome fluorescence levels of H2A.V and H2A were performed using the ImageJ software. For each histone, 25 
chromosome figures were analysed in w, elav-GAL4[w+]/w; UAS-Cfdp1[w+]/+ larvae and in w/w UAS-Cfdp1[w+]/
UAS-Cfdp1[w+] control larvae.
Cloning and preparation of DNA constructs. Full-length cDNAs of Yeti and Cfdp1 were cloned into a 
pDONR-221 (Invitrogen) and then subcloned into pDEST-15 (Invitrogen) bacterial expression vector carrying 
Glutathione S-Transferase (GST) tag N-terminally. Cfdp1 cDNA was also transferred into pcDNA3.1/nV5-DEST 
vector (Invitrogen) for transient expression of V5::CFDP1 protein in HeLa cells.
Production and precipitation of GST fusion proteins. Recombinant GST::YETI and GST::CFDP1 
were produced in BL21 (DE3) pLysS competent cells. Single clones expressing each of the individual GST fusion 
plasmids were grown in 3 ml of broth medium (LB) with ampicillin (100 g/ml) at 37 °C. Overnight cultures were 
diluted 1:20 with fresh LB with ampicillin, and grown at 37 °C to an A600 of 0.6–0.8 with vigorous agitation. 
Protein expression was induced by 1 mM isopropyl-beta-D-galactopyranoside (Sigma–Aldrich) at 37 °C for 4 h. 
GST fusion proteins were purified on 50 μ l of glutathione-coated agarose beads (Sigma–Aldrich) 1 h at 4 °C, by 
using 500 μ l of bacterial lysate (GST alone, GST::YETI and GST::CFDP1). Beads were washed three times with 
1 ml of PBS plus protease inhibitor cocktail (Roche) and stored in the same buffer. Production of proteins of the 
predicted molecular mass was verified by Western blotting using antibodies to GST (1:1000, Abgent).
GST Pull-Down assays. GST Pull-Down assays were performed by using third-instar Drosophila larvae 
expressing 3xFLAG::YETI or CFDP1 under control of elav-Gal4 driver, and HeLa cells transiently transfected 
with pcDNA3.1/nV5-DEST::CFDP1 plasmid. Whole larvae/cell extracts were prepared in GST pull-down lysis 
buffer (20 mM Tris, pH 8, 150 mM NaCl, 0.5% Nonidet P-40, 1 mM EDTA) plus protease inhibitor cocktail/1 mM 
PMSF, and then 50 l of glutathione-agarose beads with bound GST, GST::YETI, or GST::CFDP1 were added. After 
overnight incubation with rotation at 4 °C, the supernatant was removed and the beads were washed five times 
with GST pull-down lysis buffer plus protease inhibitor cocktail. Co-precipitated proteins were eluted into sample 
buffer, separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS–PAGE) and analysed by 
Western blotting.
Western blot analysis. D. melanogaster protein extracts were prepared in sample buffer from salivary 
glands and brains. HeLa cells were lysated in sample buffer at 10.000 cells/μ l. All the samples were load in a poly-
acrylamide gel, transferred onto Polyvinylidene fluoride PVDF membrane and probed with different antibodies: 
rabbit anti-H2A.V (1:2500), rabbit anti-H2A (1:2500, Millipore), mouse anti-α -Tubulin (1:10000, Sigma), mouse 
anti-CFDP1 (1:500, Sigma-Aldrich, WH0010428M4, clone 5B7); rabbit anti-GST (1:1000, Abgent, AP1298a); 
mouse anti-Flag (1:1000, Sigma-Aldrich, F1804, clone M2); mouse anti-V5 (1:1000, Thermo Scientific, R960-25). 
The bands were immunodetected using the ECL kit from Thermo Scientific.
Prediction of secondary protein structure. Prediction of α -helix stretches in the secondary structure 
of BCNT domain was performed using the Phyre2 algorithm (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.
cgi?id= index).
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